| __timestamp | TG Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 31354781 | 1488000000 |
| Thursday, January 1, 2015 | 43445817 | 1525000000 |
| Friday, January 1, 2016 | 66489820 | 2111000000 |
| Sunday, January 1, 2017 | 96886134 | 1848000000 |
| Monday, January 1, 2018 | 153793000 | 1213000000 |
| Tuesday, January 1, 2019 | 148369000 | 1010000000 |
| Wednesday, January 1, 2020 | 151934000 | 997000000 |
| Friday, January 1, 2021 | 198532000 | 967000000 |
| Saturday, January 1, 2022 | 112128000 | 838000000 |
| Sunday, January 1, 2023 | 76192000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Teva Pharmaceutical Industries Limited and TG Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Teva, a global leader, has consistently allocated substantial resources to R&D, with expenditures peaking in 2016 at approximately 2.1 billion USD. However, a noticeable decline followed, with 2023 figures showing a 55% reduction from their peak. This trend reflects Teva's strategic shift towards optimizing existing products and cost management.
Conversely, TG Therapeutics, a smaller biotech firm, has shown a steady increase in R&D spending, reaching its zenith in 2021 with a 533% rise from 2014. This growth underscores TG's aggressive pursuit of novel therapies, particularly in oncology and autoimmune diseases.
These divergent strategies highlight the dynamic nature of pharmaceutical innovation, where size and market position influence R&D priorities.
Comparing Innovation Spending: Novartis AG and Teva Pharmaceutical Industries Limited
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Summit Therapeutics Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Rhythm Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Teva Pharmaceutical Industries Limited and Vericel Corporation
R&D Insights: How Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
Exelixis, Inc. or TG Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Investment: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for TG Therapeutics, Inc. and Perrigo Company plc
Research and Development Investment: TG Therapeutics, Inc. vs Soleno Therapeutics, Inc.
TG Therapeutics, Inc. or Iovance Biotherapeutics, Inc.: Who Invests More in Innovation?